Responses Induced by Smoking in Individuals Being Susceptible and Non-Susceptible for Development of COPD
This study is not yet open for participant recruitment.
Verified December 2008 by Top Institute Pharma
Sponsor:
Top Institute Pharma
Collaborators:
University Medical Centre Groningen
UMC Utrecht
GlaxoSmithKline
Nycomed: A Takeda Company
Information provided by:
Top Institute Pharma
ClinicalTrials.gov Identifier:
NCT00807469
First received: December 11, 2008
Last updated: NA
Last verified: December 2008
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | January 2015 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |